Integra Lifesciences Holdings To Acquire Acclarent Transcript
Hello, and welcome to the Integra LifeSciences Investor Update Conference Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to turn the conference over to Chris Ward, Senior Director, Investor Relations. Please go ahead.
Thank you, Norma, and welcome, everyone. We appreciate you joining on short notice to review today's exciting announcement that Integra LifeSciences has entered into a definitive agreement to acquire the Acclarent ENT business from Johnson & Johnson. The release and corresponding presentation, which we will reference during the call, are available at integralife.com under Investors, Events and Presentations.
Joining me on the call this morning are Jan De Witte, President and Chief Executive Officer; Lea Knight, Chief Financial Officer; and Mike McBreen, Executive Vice President and President of Codman Specialty Surgical. Jan and Mike will provide a high-level overview and the strategic highlights after which, we'll open the call for Q&A.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
